Novavax to sell 1.5M more doses of its Covid vaccine to the U.S. government

Gaithersburg biotech Novavax Inc. (NASDAQ: NVAX) has reached an agreement to sell 1.5 million more doses of its Covid-19 vaccine to the U.S. government. Terms of the deal were not disclosed, but the federal government will partially fund the company’s future work on Covid vaccines, including the development of smaller dose vials and strain selection in line with Food and Drug Administration recommendations, Novavax said in its announcement.